Innovative Tongue Test Promises Faster Detection of Influenza

A novel taste-based molecular sensor using thyme flavor detection offers a quick and accessible method for early influenza diagnosis, with potential for at-home screening and pre-symptomatic detection.
As flu season approaches in the northern hemisphere, scientists are exploring novel methods for early detection to curb the spread of the virus. A recent breakthrough involves using a simple taste-based test that could replace traditional nasal swabs with a chewing gum or lozenge. This innovative approach employs a molecular sensor designed to release a distinctive thyme flavor—detected by the human tongue—when it encounters the influenza virus.
Researchers from the American Chemical Society have developed this low-tech sensor targeting the viral enzyme neuraminidase, which influenza viruses use to infect host cells. By attaching thymol, the compound responsible for thyme's herbal flavor, to a neuraminidase substrate, the sensor releases the flavor molecules when the virus is present. This interaction causes the taste of thymol to be detected instantly on the tongue, indicating a possible infection.
Laboratory tests using saliva from infected individuals demonstrated that the sensor releases thymol within 30 minutes without affecting cell health or function. The team envisions incorporating this sensor into everyday items like chewing gum or lozenges, allowing for accessible at-home screening. Such a diagnostic tool could be especially valuable because traditional tests, such as nasal swabs, although accurate, are often slow and costly, and current rapid tests may not identify pre-symptomatic infections.
The researchers aim to start human clinical trials within two years to validate the sensor’s effectiveness in detecting influenza in people before symptoms appear. If successful, this flavor-based detection method could serve as a quick, simple, and widely available first-line screening tool, particularly useful in high-risk environments. The technology is currently under patent review, marking an exciting step forward in infectious disease diagnostics.
This approach offers a promising alternative to existing testing methods, potentially helping to prevent the silent spread of influenza and other viral illnesses by enabling early, easy detection.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Link Between Semaglutide and Reduced Dementia Risk in People With Type 2 Diabetes
Studies indicate that semaglutide, a common diabetes and weight-loss drug, may significantly lower the risk of dementia in individuals with type 2 diabetes, highlighting a promising avenue for neurodegenerative disease prevention.
Innovative Smart Flooring Trial Aims to Reduce Fall-Related Injuries in Older Adults
A new study by the University of Surrey aims to develop smart flooring that reduces fall-related injuries in older adults by cushioning impacts and supporting safer mobility. This innovative research could transform fall prevention in healthcare and home environments.
Personalized Tuberculosis Treatment Strategies Based on Disease Severity Could Enhance Patient Outcomes
New research advocates for tailoring tuberculosis treatment based on disease severity, promising shorter, more effective therapies, and better patient outcomes. Learn how personalized strategies could transform TB care.



